Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In the last reported quarter, the company delivered an earnings surprise of 14.

Dublin, Ohio-based Cardinal Health, Inc. (CAH) manufactures and distributes pharmaceuticals, medical & laboratory products, ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Cardinal Health Inc. closed 4.35% short of its 52-week high of $132.84, which the company achieved on January 30th.

President Donald Trump on Saturday signed executive orders imposing sweeping tariffs on the country’s three largest trading ...

Wells Fargo analyst Stephen Baxter maintained Cardinal Health with an Equal-Weight and raised the price target from $135 to ...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share ...

Second quarter revenue for Cardinal Health's global medical products and distribution segment increased 1% to $3.2 billion, driven by volume growth from existing customers. The company’s global ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cardinal Health (CAH – Research Report) and Apyx ...